News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Constellation Pharmaceuticals Selected by AlwaysOn as an OnDC Top 100 Winner


10/8/2009 1:14:46 PM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Constellation Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing new drugs targeting epigenetic regulation of the human genome, today announced that it has been chosen by AlwaysOn as one of the OnDC Top 100 Winners. Inclusion in the OnDC 100 signifies major developments in the creation of new business opportunities that contribute to the renewed and continued prosperity of our country. Constellation Pharmaceuticals was specially selected by the AlwaysOn editorial team and industry experts spanning the globe based on a set of five criteria: innovation, market potential, commercialization, stakeholder value, and media buzz.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES